0H22 vs MCOV-B: Side-by-Side Comparison
Compare Bioinvent International AB (0H22) and Medicover AB (publ) (MCOV-B) side by side: valuation, financials, growth and model signals on Bullrun.
| Metric | 0H22 | MCOV-B |
|---|---|---|
| Company | Bioinvent International AB | Medicover AB (publ) |
| Country / Exchange | Sweden · LSE | Sweden · ST |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Medical Care Facilities |
| Market cap | — | SEK 35.40B |
| P/E ratio | — | 40.2 |
| Dividend yield | — | 0.95% |
| Valuation model | — | 23.9% undervalued |
| Revenue (latest FY) | — | — |
| Revenue growth YoY | — | — |
| Net income | — | EUR 14.60M |
| Gross margin | — | — |
| Diluted EPS | — | — |